by | Feb 25, 2026
Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional studyLeite, L. L., de Carvalho, A. V. E. & Smith, C., 25 Feb 2026, (E-pub ahead of print) In: JOURNAL OF DERMATOLOGICAL TREATMENT. 37, 1, 2627719.Research output:...
by | Feb 24, 2026
Correction to Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey [Journal of the American Academy of Dermatology 2026 Feb;94(2)633-635]Chan, K. R., Keddie, S. H., Flohr, C. & Tsoi, M. F., 24 Feb...
by | Feb 17, 2026
Integrated Methylome-Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase-Linked Immune-Epithelial Crosstalk in Atopic DermatitisMAARS Consortium, 17 Feb 2026, (E-pub ahead of print) In: Allergy.Research output: Contribution to journal › Article ›...
by | Feb 16, 2026
An Antibody-Drug Conjugate Designed Through Clone and Isotype Selection Restricts the Growth of CSPG4-Expressing Triple-Negative Breast CancerEsapa, B., Liu, Y., Chenoweth, A., Stoker, K., Łabędź, N., Romero Clavijo, P., Ilieva, K., Trendell, J., Navarro-Llinas, B.,...
by | Feb 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world dataThomas, C. M., Wei, J. R., Baudry, D., Arkir, Z., Coker, B., Dasandi, T., Powell, K., Arenas-Hernandez, M., Leung, J., Rawstron, K., Nwaogu, C., Woolf, R., Pink, A....